SCHEDULE 13G 0001284386 XXXXXXXX LIVE Ordinary Shares, no par value 12/31/2025 0001912966 REGENTIS BIOMATERIALS LTD. M8211G108 60 Medinat Hayehudim L3 4676652 Rule 13d-1(d) Dr. Ehud Geller L3 0.00 1332867.00 0.00 1332867.00 1332867.00 N 23.2 IN (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants. Medica III Investments (International) L.P. E9 0.00 1332867.00 0.00 1332867.00 1332867.00 N 23.2 PN (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants. Medica III Investments (Israel) L.P. L3 0.00 1332867.00 0.00 1332867.00 1332867.00 N 23.2 PN (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants. Medica III Investments (S.F.) L.P. E9 0.00 1332867.00 0.00 1332867.00 1332867.00 N 23.2 PN (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants. Medica III Investments (P.F.) L.P. L3 0.00 1332867.00 0.00 1332867.00 1332867.00 N 23.2 PN (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants. Medica III Investments Israel (B) L.P. L3 0.00 1332867.00 0.00 1332867.00 1332867.00 N 23.2 PN (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants. Poalim Medica III Investments L.P. L3 0.00 1332867.00 0.00 1332867.00 1332867.00 N 23.2 PN (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants. REGENTIS BIOMATERIALS LTD. 60 Medinat Hayehudim, 4676652, Israel. The following entities and individual, listed below, who are filing this Statement of Beneficial Ownership on Schedule 13G (this "Statement"), are referred to herein collectively as the "Reporting Persons": 1. Ehud Geller, an Israeli Citizen; 2. Medica III Investments (International) L.P. a Cayman Islands limited Partnership; 3. Medica III Investments (Israel) L.P. an Israeli limited partnership; 4. Medica III Investments (S.F.) L.P. a Cayman Islands limited partnership; 5. Medica III Investments (P.F.) L.P. an Israeli limited partnership; 6. Medica III Investments (Israel) (B) L.P. an Israeli limited partnership; and 7. Poalim Medica III Investments L.P. an Israeli limited partnership. The principal business address of the Reporting Persons is 60C Medinat Hayehudim, Herzliya, 4676670, Israel. Each of the entities or persons identified in Item 2(a) above is a corporation, limited partnership or individual organized under the laws of the jurisdiction, or is a citizen of the jurisdiction, as applicable, set forth opposite such entity's or person's name. Y Dr. Ehud Geller 1,332,867.00 Ordinary Shares Medica III Investments (International) L.P. 1,332,867.00 Ordinary Shares Medica III Investments (Israel) L.P. 1,332,867.00 Ordinary Shares Medica III Investments (S.F.) L.P. 1,332,867.00 Ordinary Shares Medica III Investments (P.F.) L.P. 1,332,867.00 Ordinary Shares Medica III Investments Israel (B) L.P. 1,332,867.00 Ordinary Shares Poalim Medica III Investments L.P. 1,332,867.00 Ordinary Shares Dr. Ehud Geller 23.2%* Medica III Investments (International) L.P. 23.2%* Medica III Investments (Israel) L.P. 23.2%* Medica III Investments (S.F.) L.P. 23.2%* Medica III Investments (P.F.) L.P. 23.2%* Medica III Investments Israel (B) L.P. 23.2%* Poalim Medica III Investments L.P. 23.2%* * This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants. Dr. Ehud Geller 0 Medica III Investments (International) L.P. 0 Medica III Investments (Israel) L.P. 0 Medica III Investments (S.F.) L.P. 0 Medica III Investments (P.F.) L.P. 0 Medica III Investments Israel (B) L.P. 0 Poalim Medica III Investments L.P. 0 Dr. Ehud Geller 1,332,867 Medica III Investments (International) L.P. 1,332,867 Medica III Investments (Israel) L.P. 1,332,867 Medica III Investments (S.F.) L.P. 1,332,867 Medica III Investments (P.F.) L.P. 1,332,867 Medica III Investments Israel (B) L.P. 1,332,867 Poalim Medica III Investments L.P. 1,332,867 Dr. Ehud Geller 0 Medica III Investments (International) L.P. 0 Medica III Investments (Israel) L.P. 0 Medica III Investments (S.F.) L.P. 0 Medica III Investments (P.F.) L.P. 0 Medica III Investments Israel (B) L.P. 0 Poalim Medica III Investments L.P. 0 Dr. Ehud Geller 1,332,867 Medica III Investments (International) L.P. 1,332,867 Medica III Investments (Israel) L.P. 1,332,867 Medica III Investments (S.F.) L.P. 1,332,867 Medica III Investments (P.F.) L.P. 1,332,867 Medica III Investments Israel (B) L.P. 1,332,867 Poalim Medica III Investments L.P. 1,332,867 N Y Y Y Y Y Y Dr. Ehud Geller /s/ Ehud Geller 02/17/2026 Medica III Investments (International) L.P. /s/ Ehud Geller 02/17/2026 Medica III Investments (Israel) L.P. /s/ Ehud Geller 02/17/2026 Medica III Investments (S.F.) L.P. /s/ Ehud Geller 02/17/2026 Medica III Investments (P.F.) L.P. /s/ Ehud Geller 02/17/2026 Medica III Investments Israel (B) L.P. /s/ Ehud Geller 02/17/2026 Poalim Medica III Investments L.P. /s/ Ehud Geller 02/17/2026